Monocytic leukemia in a horse.

This case report describes a 6-year-old gelding with widespread illness caused by cancer of the monocyte lineage (monocytic leukemia), confirmed by blood tests, tissue examination, and specialized cell-staining and microscopy techniques. The disease infiltrated many organs, caused fluid build-up and swollen lymph nodes, and was definitively identified by the cells’ phagocytic behavior and characteristic enzyme-staining pattern.

What the report is about

• A detailed veterinary case of monocytic leukemia in a horse, documenting clinical signs, laboratory abnormalities, postmortem (necropsy) findings, and multiple diagnostic techniques used to determine the leukemic cell lineage.
• The authors correlate the horse’s systemic illness (respiratory difficulty, edema, poor performance) with extensive infiltration of organs by malignant monocytoid cells.

Clinical presentation and physical examination

• Signalment and history: a 6-year-old Hassian gray gelding with impaired performance, intermittent cough, episodes of colic, and edema affecting the ventral abdomen, prepuce, and legs.
• Physical findings: reduced skin turgor (suggesting dehydration or poor perfusion), pale mucous membranes (consistent with anemia), forced costoabdominal breathing (indicative of respiratory compromise), reduced venous return, generalized lymphadenopathy (enlarged lymph nodes), and splenomegaly.
• Clinical interpretation: the constellation suggests a systemic process affecting blood formation and circulation, with possible fluid accumulation in body cavities and lymphatic/venous congestion from widespread infiltrative disease.

Hematology and cytology

• Hematologic abnormalities included anemia and leukocytosis with a high percentage of monocytoid leukemic cells in peripheral blood.
• The predominance of abnormal monocytoid cells in blood points to a primary leukemia rather than a localized tumor with secondary inflammation.
• Functionally, the leukemic cells displayed phagocytosis of latex particles in vitro, a hallmark behavior of cells of the monocyte/macrophage lineage.

Postmortem (necropsy) findings

• Gross changes: generalized lymphadenopathy and splenomegaly; fluid accumulations including ascites (abdominal) and hydrothorax (pleural); and a diffusely thickened intestinal wall.
• Microscopic distribution: massive infiltration by monocytoid leukemic cells in lymph nodes, spleen, bone marrow, liver, intestinal wall, kidneys, and choroid plexus.
• Pathophysiologic implications:
  • Bone marrow infiltration explains anemia (replacement of normal hematopoietic tissue) and extreme leukocytosis with malignant monocytoid cells.
  • Lymph node and splenic enlargement reflect tumor burden.
  • Gut wall thickening may impair absorption and protein balance, potentially contributing to edema and effusions.
  • Serosal effusions (ascites, hydrothorax) likely result from a combination of venous/lymphatic obstruction by infiltrated tissues and altered vascular permeability from neoplastic infiltration.
  • Choroid plexus involvement underscores the disseminated nature of disease and potential for neurologic complications.

Cell-lineage determination: cytochemistry and functional assays

• Phagocytosis assay: leukemic cells actively engulfed latex particles under light and electron microscopy, supporting a monocyte/macrophage phenotype.
• Cytochemical enzyme staining profile:
  • Strong alpha-naphthyl-acetate esterase and naphthol-AS-acetate esterase activity (nonspecific esterases) — characteristic of monocytes.
  • Only weak positivity for naphthol-AS-D-chloroacetate esterase (specific esterase) — argues against a granulocytic (neutrophil) lineage.
  • Very weak alkaline phosphatase activity, seen only in a few leukemic cells — not supportive of a neutrophilic process.
• Scanning electron microscopy (SEM):
  • Cells displayed prominent surface ruffles and ridge-like profiles, ultrastructural features typical of monocytes/macrophages with active membrane dynamics.
• Integrated interpretation: the combination of strong nonspecific esterase activity, phagocytic function, weak specific esterase, and SEM morphology robustly identifies a monocytoid (monocytic) leukemia.

Differential diagnosis and diagnostic reasoning

• Lymphocytic leukemia/lymphoma:
  • Less likely due to the strong nonspecific esterase profile and confirmed phagocytosis, which are not features of lymphoid blasts.
  • Although generalized lymphadenopathy was present, cytochemical and functional evidence argue against lymphoid origin.
• Granulocytic (myeloid/neutrophilic) leukemia:
  • Weakened naphthol-AS-D-chloroacetate esterase activity and very low alkaline phosphatase activity are inconsistent with granulocytic lineage.
• Myelomonocytic leukemia:
  • Could be considered if there were substantial granulocytic features; however, the staining profile and morphology emphasize a predominantly monocytic phenotype.
• Conclusion: monocytic leukemia was diagnosed by exclusion of lymphocytic and granulocytic leukemias and by converging cytochemical, functional, and ultrastructural evidence.

How the clinical signs relate to the disease process

• Pale mucous membranes and reduced performance: reflect anemia and decreased oxygen-carrying capacity.
• Forced costoabdominal breathing and hydrothorax: pleural effusion impedes lung expansion, producing labored breathing.
• Edema of ventral abdomen, prepuce, and legs:
  • From increased hydrostatic pressure (venous/lymphatic obstruction by infiltrated nodes and organs) and possibly decreased oncotic pressure (intestinal involvement affecting protein metabolism or loss).
• Colic and thickened gut wall: leukemic infiltration of the intestine can cause motility disturbances, wall thickening, and discomfort.
• Reduced venous return: mechanical impedance from enlarged nodes/organs and effusions contributes to circulatory compromise.

Classification considerations

• The findings are most consistent with a monocytic leukemia within the acute myeloid leukemia spectrum (analogous to acute monocytic leukemia in human FAB classification).
• Extensive organ infiltration and high circulating tumor burden favor an aggressive, systemic process with poor prognosis in equine patients.

Diagnostic methods highlighted by this case

• Peripheral blood smear and differential counts to detect leukocytosis and identify monocytoid cells.
• Cytochemical staining panels to distinguish myeloid lineages:
  • Nonspecific esterases (alpha-naphthyl-acetate, naphthol-AS-acetate) for monocytes.
  • Specific esterase (naphthol-AS-D-chloroacetate) for granulocytes.
  • Alkaline phosphatase for neutrophil activity (low here).
• Functional assays (phagocytosis of latex beads) to confirm monocyte/macrophage behavior.
• Electron microscopy (scanning and transmission) to assess cell-surface morphology and intracellular phagolysosomes.
• Comprehensive necropsy to map the distribution and severity of infiltration across organs.

Implications for veterinary practice

• Awareness: Leukemia, though uncommon in horses, should be considered when faced with unexplained anemia, leukocytosis, generalized lymphadenopathy, effusions, and splenomegaly.
• Diagnostic strategy: Combining hematology, cytochemistry, functional assays, and imaging/pathology provides a reliable path to lineage-specific diagnosis.
• Prognosis and management: Monocytic leukemia with multi-organ infiltration is typically grave; options are limited in equine medicine, and supportive or palliative care is often the focus. Early recognition may guide humane decision-making.

Limitations and open questions

• This is a single case; it cannot define incidence or typical progression in the broader equine population.
• Molecular characterization (e.g., immunophenotyping or genetic testing) is not reported; modern adjuncts could further refine classification and pathogenesis.
• Therapeutic exploration (chemotherapy feasibility, targeted care) remains an area for future veterinary oncology research in horses.

Key takeaways

• Monocytic leukemia can present in horses with systemic signs driven by infiltration and effusions.
• Phagocytic activity plus a cytochemical profile of strong nonspecific esterase and weak specific esterase staining is decisive for monocytic lineage.
• Extensive organ involvement at necropsy corroborates the aggressive, disseminated nature of this leukemia.